Phathom Pharmaceuticals Inc (PHAT)
Cost of Revenue
$15.10M
Quarterly · Period ending: · USD
PHAT Cost of Revenue
Latest reported$15.10Mperiod ending
Latest reported$15.10Mperiod ending
PHAT Quarterly Cost of Revenue ($0.00 → $15.10M)
Quarterly cost of revenue
High-resolution chart · PNG
PHAT cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 15,096,000 | |
| 11,996,000 | |
| 7,648,000 | |
| 6,190,000 | |
| 5,038,000 | |
| 3,724,000 | |
| 3,815,000 | |
| 2,356,000 | |
| 1,376,000 | |
| 426,000 | |
| 352,000 | |
| 121,000 | |
| 123,000 | |
| 0 | |
| 168,000 | |
| 175,000 | |
| 149,000 | |
| 128,000 | |
| 135,000 | |
| 130,000 | |
| 131,000 | |
| 125,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |